Aller au contenu principal
IngrédientMise à jour CosIng 14 Oct 2019

CAPROLACTAM

2H-Azepin-2-one, hexahydro-

CAPROLACTAM figure dans l’inventaire CosIng de l’UE, mais aucune fiche d’annexe directe n’est encore associée sur cette page.

En un coup d’œil

Fonction
Not reported
CAS
105-60-2
EC
203-313-2
Annexes de l’UE
Non répertoriéAucune fiche d’annexe de l’UE n’est associée. Ce n’est pas une autorisation.

Preuves réglementaires par marché

Aucune règle pour cet ingrédient n’a été importée pour aucun des 13 marchés suivis ici.

Cela décrit cet inventaire, et non le droit. L’absence de règle importée n’est pas la preuve qu’un ingrédient est autorisé : une règle peut exister sous un autre nom ou identifiant, ou dans un jeu de données pas encore importé ici.

Détails d’inventaire pour CAPROLACTAM

Nom INCI

CAPROLACTAM

Description

2H-Azepin-2-one, hexahydro-

Provenance de la fiche

Référence d’inventaire
97428
Identité importée
CAPROLACTAM
Mise à jour de la source
14/10/2019
Notes de source CosIng de la Commission européenne

Données clés

Restriction
—
Fonction

Identité et propriétés chimiques

Structure chimique 2D PubChem pour le CAS 105-60-2
CAS 105-60-2PubChem CID 7768

Caprolactam

Epsilon-caprolactam is a member of the class of caprolactams that is azepane substituted by an oxo group at position 2. It has a role as a human blood serum metabolite. — ChEBI

Nom IUPAC
azepan-2-one
Formule moléculaire
C6H11NO
Masse moléculaire
113.16 g/mol
Masse exacte
113.084063974 Da
XLogP3
-0,1
Surface polaire topologique
29,1 Ų
Donneurs de liaisons hydrogène
1
Accepteurs de liaisons hydrogène
1
Unités covalentes
1
Stéréocentres définis
0

Également connu sous le nom de

epsilon-Caprolactam2-Oxohexamethylenimine6-CaprolactamAminocaproic lactamHexahydro-2H-azepin-2-one6-Hexanelactam2-Oxohexamethyleneimine2-Azacycloheptanone
16 autres noms signalés
Hexanolactam2H-Azepin-2-one, hexahydro-Hexahydro-2-azepinone2-Perhydroazepinone1,6-HexolactamHexanone isoximeHexanonisoximCaprolattame2-KetohexamethylenimineCyclohexanone iso-oxime2-Ketohexamethyleneimine1-Aza-2-cycloheptanoneCaprolactam monomerEpsylon kaprolaktam6-Aminocaproic acid lactamExtrom 6N
Identifiants de bases de données externes

Preuves issues de bases de données scientifiques complémentaires

EMBL-EBI ChEBI
Correspondance exacte d’identifiantCHEBI:28579

ε-caprolactam

A member of the class of caprolactams that is azepane substituted by an oxo group at position 2.

Formule
C6H11NO
Masse moyenne
113.160 g/mol
Masse monoisotopique
113.08406 Da
Charge formelle
0
  • caprolactams — is a (CHEBI:23000)
  • human blood serum metabolite — has role (CHEBI:85234)
  • human blood serum metabolite — has role (CHEBI:85234)
  • caprolactams — is a (CHEBI:23000)
Noms supplémentaires validés
azepan-2-one2-ketohexamethyleneimine2-oxohexamethylenimine6-caprolactamaminocaproic lactamcaprolactamepsilon-Caprolactamhexahydro-2H-azepin-2-oneKaprolaktamepsilon-caprolactam
Références croisées de cette source
  • REGISTRY_NUMBER: 101802 — Gmelin
  • REGISTRY_NUMBER: 106934 — Reaxys
  • CAS: 105-60-2 — KEGG COMPOUND
  • CAS: 105-60-2 — ChemIDplus
  • CAS: 105-60-2 — NIST Chemistry WebBook
  • MANUAL_X_REF: C00000318 — KNApSAcK
  • MANUAL_X_REF: c0432 — UM-BBD
  • MANUAL_X_REF: C06593 — KEGG COMPOUND
  • MANUAL_X_REF: Caprolactam — Wikipedia
  • MANUAL_X_REF: CPD-883 — MetaCyc
  • MANUAL_X_REF: ICC — PDBeChem
  • MANUAL_X_REF: KR20120003540 — Patent
  • MANUAL_X_REF: US2011183386 — Patent
  • MANUAL_X_REF: WO2011108251 — Patent

Mis en correspondance par: Exact CAS cross-reference in the ChEBI compound record. Source mise à jour le: 2020-05-21. Récupéré le: 2026-08-31. Ouvrir la fiche source

NIH PubChem PUG-View
Correspondance exacte d’identifiant7768

Attributed physical-property, hazard, environmental and use annotations.

  • First Aid: EYES: First check the victim for contact lenses and remove if present. Flush victim's eyes with water or normal saline solution for 20 to 30 minutes while simultaneously calling a hospital or poison control center. Do not put any ointments, oils, or medication in the victim's eyes without specific instructions from a physician. IMMEDIATELY transport the victim after flushing eyes to a hospital even if no symptoms (such as redness or irritation) develop.; SKIN: IMMEDIATELY flood affected skin with water while removing and isolating all contaminated clothing. Gently wash all affected skin areas thoroughly with soap and water. If symptoms such as redness or irritation develop, IMMEDIATELY call a physician and be prepared to transport the victim to a hospital for treatment.; INHALATION: IMMEDIATELY leave the contaminated area; take deep breaths of fresh air. If symptoms (such as wheezing, coughing, shortness of breath, or burning in the mouth, throat, or chest) develop, call a physician and be prepared to transport the victim to a hospital. Provide proper respiratory protection to rescuers entering an unknown atmosphere. Whenever possible, Self-Contained Breathing Apparatus (SCBA) shou Source: CAMEO Chemicals
  • First Aid: (General first aid procedures); Eye: Irrigate immediately - If this chemical contacts the eyes, immediately wash (irrigate) the eyes with large amounts of water, occasionally lifting the lower and upper lids. Get medical attention immediately.; Skin: Water wash immediately - If this chemical contacts the skin, immediately wash the contaminated skin with water. If this chemical penetrates the clothing, immediately remove the clothing and wash the skin with water. If symptoms occur after washing, get medical attention immediately.; Breathing: Respiratory support; Swallow: Medical attention immediately - If this chemical has been swallowed, get medical attention immediately. Source: The National Institute for Occupational Safety and Health (NIOSH)
  • Signal: Warning Source: Regulation (EC) No 1272/2008 of the European Parliament and of the Council
  • GHS Hazard Statements: H302: Harmful if swallowed [Warning Acute toxicity, oral]; H315: Causes skin irritation [Warning Skin corrosion/irritation]; H319: Causes serious eye irritation [Warning Serious eye damage/eye irritation]; H332: Harmful if inhaled [Warning Acute toxicity, inhalation]; H335: May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation] Source: Regulation (EC) No 1272/2008 of the European Parliament and of the Council
  • Precautionary Statement Codes: P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P317, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement) Source: Regulation (EC) No 1272/2008 of the European Parliament and of the Council
  • Note: This chemical does not meet GHS hazard criteria for < 0.1% (1 of 1874) of reports. Source: European Chemicals Agency (ECHA)
  • Signal: Warning Source: European Chemicals Agency (ECHA)
  • GHS Hazard Statements: H302 (99.9%): Harmful if swallowed [Warning Acute toxicity, oral]; H315 (99.9%): Causes skin irritation [Warning Skin corrosion/irritation]; H319 (99.9%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]; H332 (99.9%): Harmful if inhaled [Warning Acute toxicity, inhalation]; H335 (95.8%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation] Source: European Chemicals Agency (ECHA)
  • Precautionary Statement Codes: P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P317, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement) Source: European Chemicals Agency (ECHA)
  • ECHA C&L Notifications Summary: Aggregated GHS information provided per 1874 reports by companies from 31 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.; Reported as not meeting GHS hazard criteria per 1 of 1874 reports by companies.; There are 30 notifications provided by 1873 of 1874 reports by companies with hazard statement code(s).; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. Source: European Chemicals Agency (ECHA)
  • Signal: Danger Source: NITE-CMC
  • GHS Hazard Statements: H302: Harmful if swallowed [Warning Acute toxicity, oral]; H312: Harmful in contact with skin [Warning Acute toxicity, dermal]; H315: Causes skin irritation [Warning Skin corrosion/irritation]; H319: Causes serious eye irritation [Warning Serious eye damage/eye irritation]; H335: May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]; H361: Suspected of damaging fertility or the unborn child [Warning Reproductive toxicity]; H371: May cause damage to organs [Warning Specific target organ toxicity, single exposure]; H372: Causes damage to organs through prolonged or repeated exposure [Danger Specific target organ toxicity, repeated exposure] Source: NITE-CMC
  • Precautionary Statement Codes: P203, P260, P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P308+P316, P317, P318, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement) Source: NITE-CMC
  • GHS Hazard Statements: H302: Harmful if swallowed [Warning Acute toxicity, oral]; H312: Harmful in contact with skin [Warning Acute toxicity, dermal]; H316: Causes mild skin irritation [Warning Skin corrosion/irritation]; H319: Causes serious eye irritation [Warning Serious eye damage/eye irritation]; H335: May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]; H336: May cause drowsiness or dizziness [Warning Specific target organ toxicity, single exposure; Narcotic effects]; H370: Causes damage to organs [Danger Specific target organ toxicity, single exposure]; H372: Causes damage to organs through prolonged or repeated exposure [Danger Specific target organ toxicity, repeated exposure] Source: NITE-CMC
  • Environmental Bioconcentration: An estimated BCF of 3.2 was calculated for caprolactam(SRC), using an estimated log Kow of 0.66(1,SRC) and a regression-derived equation(2). According to a classification scheme(3), this BCF suggests the potential for bioconcentration in aquatic organisms is low. Source: Hazardous Substances Data Bank (HSDB)
  • Environmental Fate: TERRESTRIAL FATE: Based on a classification scheme(1), an estimated Koc value of 57(SRC), determined from a structure estimation method(2), indicates that caprolactam is expected to have high mobility in soil(SRC). Volatilization of caprolactam from moist soil surfaces is not expected to be an important fate process(SRC) given an estimated Henry's Law constant of 5.4X10-11 atm-cu m/mole from its vapor pressure, 1.9X10-3 mm Hg at 25 °C(5), and water solubility, 5.25X10+6 mg/l(6). Caprolactam is not expected to volatilize from dry soil surfaces(SRC) based upon a vapor pressure of 1.9X10-3 mm Hg at 25 °C(5). Caprolactam is degraded in aquatic environments with a half life of 5 to 15 days, and is expected to be degraded in aerobic soils in a similar timeframe(6). Source: Hazardous Substances Data Bank (HSDB)
  • Environmental Fate: AQUATIC FATE: Based on a classification scheme(1), an estimated Koc value of 57(SRC), determined from an estimation method(2), indicates that caprolactam is not expected to adsorb to suspended solids or to sediments in water(SRC). Volatilization from water surfaces is not expected(3) based upon an estimated Henry's Law constant of 5.4X10-11 atm-cu m/mole(SRC) calculated from its vapor pressure, 1.9X10-3 mm Hg at 25 °C(4), and water solubility, 5.25X10+6 mg/l(5). According to a classification scheme(6), an estimated BCF of 3.1(SRC), from an estimated log Kow of 0.66(7) suggests the potential for bioconcentration in aquatic organisms is low. Biodegradation in aquatic environments is expected to be extensive; complete degradation of 50-100 ug/ml caprolactam was observed in nutrient-amended or sediment-associated lake water in 21 days(8). Slightly less caprolactam was degraded (36-85%) after 21 days if higher concentrations (1000 to 2000 ug/ml) were used. However, in none of these control cases was any complete degradation (mineralization) of the caprolactam observed. Based on very slow hydrolysis rates of other aliphatic acid amides, hydrolysis is not expected to be an important fate Source: Hazardous Substances Data Bank (HSDB)
  • Environmental Fate: ATMOSPHERIC FATE: According to a model of gas/particle partitioning of semivolatile organic compounds in the atmosphere(1), caprolactam, which has a vapor pressure of 1.9X10-3 mm Hg at 25 °C(4), is expected to exist solely as a vapor in the ambient atmosphere. Vapor-phase caprolactam is degraded in the atmosphere by reaction with photochemically-produced hydroxyl radicals(SRC); the half-life for this reaction in air is estimated to be 21 hours(SRC), calculated from its rate constant of 18X10-12 cu cm/molecule-sec at 25 °C(3). Caprolactam does not absorb light in the environmental spectrum (>290 nm), indicating there is little potential for direct photolysis. Source: Hazardous Substances Data Bank (HSDB)
  • Industry Uses: Dye; Intermediate; Catalyst; Not Known or Reasonably Ascertainable; Processing aids not otherwise specified; Monomers; Solvent Source: EPA Chemical Data Reporting (CDR)
  • Uses: Caprolactam is primarily used in the manufacture of synthetic fibers (especially Nylon 6). Caprolactam is also used in brush bristles, textile stiffeners, film coatings, synthetic leather, plastics, plasticizers, paint vehicles, cross-linking for polyurethanes, and in the synthesis of lysine. Source: EPA Hazardous Air Pollutants
  • Sources/Uses: Used as a monomer for synthetic fibers, plastics, coatings, plasticizers, and paint vehicles and as a cross-linking agent for polyurethanes. [ACGIH] Source: Haz-Map, Information on Hazardous Chemicals and Occupational Diseases
  • Industrial Processes with risk of exposure: Painting (Pigments, Binders, and Biocides) [Category: Paint]; Plastic Composites Manufacturing [Category: Industry] Source: Haz-Map, Information on Hazardous Chemicals and Occupational Diseases
  • Uses: Mfr synthetic fibers of the polyamide type (Perlon); solvent for high mol wt polymers Source: Hazardous Substances Data Bank (HSDB)
  • Uses: Manufacture of synthetic fibers (especially nylon 6), plastics, bristles, film, coatings, synthetic leather, plasticizers and paint vehicles, cross-linking agent for polyurethanes, synthesis of amino acid lysine. Source: Hazardous Substances Data Bank (HSDB)
  • Uses: US FDA PERMITS USE OF CAPROLACTAM ETHYLENE-ETHYL ACRYLATE GRAFT POLYMERS AS COMPONENT OF SIDE SEAM CEMENTS INTENDED FOR USE IN CONTACT WITH FOOD ... Source: Hazardous Substances Data Bank (HSDB)

Mis en correspondance par: Existing checksum-valid CAS to unique PubChem CID match. Récupéré le: 2026-08-31. Ouvrir la fiche source

Les classifications scientifiques et les annotations de danger apportent du contexte et ne remplacent pas la décision réglementaire propre au marché indiquée ci-dessus.

Couverture des sources complémentaires et état des correspondances
SourceRésultatVérifié
EMBL-EBI ChEBICorrespondance exacte2026-08-31
NIH PubChem PUG-ViewCorrespondance exacte2026-08-31

Une absence de correspondance enregistrée est une preuve utile que la source a été vérifiée ; ce n’est pas l’affirmation que la substance n’existe pas ailleurs.

Récupéré depuis NIH PubChem le 2026-08-31 par correspondance CAS à somme de contrôle valide. Les propriétés chimiques ne remplacent pas la décision réglementaire de cette page.

Ingrédients ayant des fonctions de formulation communes

Sources officielles et scientifiques complémentaires

11 bases de données externes pour vérifier cette identité

Comment CAPROLACTAM apparaît dans l’inventaire CosIng

L’inventaire CosIng répertorie CAPROLACTAM comme ingrédient cosmétique et cette page l’associe à 0 fiche d’annexe. L’entrée d’inventaire reprend les noms et identifiants, tandis que la fiche d’annexe indique où la substance est interdite, soumise à restrictions ou inscrite sur une liste positive dans le droit de l’UE sur les cosmétiques.

CAPROLACTAM est aussi associé à 1 fonction cosmétique dans les données officielles. Les désignations de fonction décrivent l’usage prévu, mais ne remplacent pas l’examen réglementaire des fiches d’annexe associées avant un travail de formulation ou d’étiquetage.

Questions fréquentes

CAPROLACTAM figure dans l’inventaire des ingrédients CosIng de l’UE, sans fiche de restriction d’annexe directement associée pour le moment. L’absence de lien avec une annexe ne garantit pas une utilisation sans restriction ; vérifiez toujours auprès de la base de données officielle CosIng actuelle avant de formuler.

Selon l’inventaire CosIng de l’UE, CAPROLACTAM porte la ou les désignations de fonction suivantes :

Le CAS 105-60-2 peut apparaître dans plusieurs fiches d’annexe de l’UE. La page de recherche par CAS présente toutes les entrées des annexes II à VI partageant cet identifiant, ce qui est utile pour déterminer le statut réglementaire transversal aux annexes d’une même substance chimique.

Utilisez le vérificateur INCI pour analyser une liste d’ingrédients complète sur des marchés sélectionnés, ou comparez cette substance sur tous les jeux de données de marchés pris en charge.

Note de source pour CAPROLACTAM

Cette page reproduit l’entrée d’inventaire CosIng de CAPROLACTAM issue de documents publics de la Commission européenne sur les ingrédients cosmétiques et affiche les identifiants associés, même si aucune correspondance directe avec une annexe n’est actuellement rattachée.

Utilisez cette page d’inventaire pour étudier CAPROLACTAM et comparer les fiches associées, mais vérifiez les restrictions et le statut juridique auprès du texte officiel en vigueur et de la législation avant toute décision réglementaire.

Outils et étapes suivantes

Vérifiez votre formule

Analysez une liste INCI complète pour détecter CAPROLACTAM et les éventuelles restrictions d’annexes de l’UE ou signalements d’allergènes associés.

Vérificateur INCI

Rechercher des ingrédients similaires

Trouvez d’autres ingrédients de l’inventaire et entrées d’annexe liés à CAPROLACTAM, à ses identifiants ou à des variantes de nom proches.

Rechercher